Skip to main content
. 2015 Jul 30;5:12584. doi: 10.1038/srep12584

Figure 6. Densitometric analysis (OD Units) of p-ERK1/2 normalised to t-ERK1/2.

Figure 6

Cells were treated with 100 nM of OXA (a) OXB (b) or QRFP (c) in the presence of the OXR antagonists SB (SB-334867) and TCS (TCS OX 229; (d-f). *p < 0.05, **p < 0.01, ***p < 0.001 to no supplement (NS).